[1]
M. Husin, “Effectiveness of homologous and heterologous BNT162b2 and CoronaVac booster vaccination against severe COVID-19 outcomes”, J Infect Dev Ctries, vol. 19, no. 01, pp. 9–12, Jan. 2025.